Last reviewed · How we verify
Gram stain-guided antibiotic choice
At a glance
| Generic name | Gram stain-guided antibiotic choice |
|---|---|
| Sponsor | Osaka General Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Impact of Rapid Pathogen Detection in ICU Patients With Suspected Pneumonia on Antimicrobial Therapy (PHASE2)
- GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Gram stain-guided antibiotic choice CI brief — competitive landscape report
- Gram stain-guided antibiotic choice updates RSS · CI watch RSS
- Osaka General Medical Center portfolio CI